Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Significance of Artificial Intelligence-Guided Psychotherapy of Depression and Anxiety Disorders

NCT07576686 is registered in ClinicalTrials.gov with Aleksandra Stojanovic as lead sponsor.

NCT NCT07576686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07576686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Significance of Artificial Intelligence-Guided Psychotherapy of Depression and Anxiety Disorders
Lead sponsor
Aleksandra Stojanovic
Phase
Not applicable
Overall status
Recruiting
Start date
January 7, 2026
Completion date
June 10, 2026
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorders, depression - major depressive disorder